pps too low, net equity still positive, imo commons will retain some value here, 0.15 would be 3x current pps, a 200% gain, excellent! Definitively undervalued, all we need is oil bounce and volumes!
crazy crazy crazy, this stock should be well over 2$ with 2 ongoing PH3 in prostate cancer!
a powerful cash position, strong product pipeline, market overreaction yesterday
Leukadia trading off, suspended because of announcment
easy 5$ at re-open imo
we'll see, very cheap now, based on potential 1$pps the new public company, Tobira, is worth only 106mln$ with more than half in cash, excluding future issues, financings and potential partnerships